Neonatal Medicine

The Korean Society of Neonatology (대한신생아학회)
권호 표지
DOI QR코드

DOI QR Code

A Case of Platyspondylic Lethal Skeletal Dysplasia Torrance Type

  • Lee, Sung Chan (Department of Pediatrics, Chosun University College of Medicine) ;
  • Choi, Min Seon (Department of Pediatrics, Chosun University College of Medicine)
  • Received : 2017.09.14
  • Accepted : 2017.10.22
  • Published : 2018.02.28
⟨ Previous Next ⟩

Abstract

Platyspondylic lethal skeletal dysplasia, Torrance type (PLSD-T), is one of the pheno-types of type II collagenopathy and is characteristic of severe bone growth disorder. This phenotype may limit the growth and expansion of the lungs, which is known to cause death from respiratory failure during or shortly after birth, but in few less severe cases, patients have been reported to have survived to adulthood. We have experienced a case of PLSD-T in a preterm infant who was delivered via cesarean section at the gestational age of 29 weeks 3 days, with a birth weight of 1.15 kg. Physical examination of the infant revealed characteristic findings of short arms and legs, small thorax, distended abdomen, and cleft palate. On the basis of the subsequent genetic testing, the patient had a heterozygous mutation in the encoded c-propeptide region of collagen, type II, alpha 1 (COL2A1), c.4335G>A ($p.Trp1445^{\ast}$) in exon 52. This is the first case of PLSD-T diagnosed in Korea, and we hereby report the case.

Keywords

References

  1. Nishimura G, Nakashima E, Mabuchi A, Shimamoto K, Shimamoto T, Shimao Y, et al. Identification of COL2A1 mutations in platyspondylic skeletal dysplasia, Torrance type. J Med Genet 2004;41:75-9. https://doi.org/10.1136/jmg.2003.013722
  2. Zankl A, Neumann L, Ignatius J, Nikkels P, Schrander-Stumpel C, Mortier G, et al. Dominant negative mutations in the C-propeptide of COL2A1 cause platyspondylic lethal skeletal dysplasia, Torrance type, and define a novel subfamily within the type 2 collagenopathies. Am J Med Genet Part A 2005;133A:61-7. https://doi.org/10.1002/ajmg.a.30531
  3. Okamoto T, Nagaya K, Asai H, Tsuchida E, Nohara F, Hayashi T, et al. Platyspondylic lethal dysplasia Torrance type with a heterozygous mutation in the triple helical domain of COL2A1 in two sibs from phenotypically normal parents. Am J Med Genet A 2012;158a:1953-6. https://doi.org/10.1002/ajmg.a.35509
  4. Neumann L, Kunze J, Uhl M, Stover B, Zabel B, Spranger J. Survival to adulthood and dominant inheritance of platyspondylic skeletal dysplasia, Torrance-Luton type. Pediatr Radiol 2003;33:786-90. https://doi.org/10.1007/s00247-003-1055-x
  5. Desir J, Cassart M, Donner C, Coucke P, Abramowicz M, Mortier G. Spondyloperipheral dysplasia as the mosaic form of platyspondylic lethal skeletal dyplasia Torrance type in mother and fetus with the same COL2A1 mutation. Am J Med Genet Part A 2012;158A:1948-52. https://doi.org/10.1002/ajmg.a.35301
  6. Horton WA, Rimoin DL, Hollister DW, Lachman RS. Further heterogeneity within lethal neonatal short-limbed dwarfism: the platyspondylic types. J Pediatr 1979;94:736-42. https://doi.org/10.1016/S0022-3476(79)80140-7
  7. Spranger J, Winterpacht A, Zabel B. The type II collagenopathies: a spectrum of chondrodysplasias. Eur J Pediatr 1994;153:56-65.
  8. Zabel B, Hilbert K, Stoss H, Superti-Furga A, Spranger J, Winterpacht A. A specific collagen type II gene (COL2A1) mutation presenting as spondyloperipheral dysplasia. Am J Med Genet 1996;63:123-8. https://doi.org/10.1002/(SICI)1096-8628(19960503)63:1<123::AID-AJMG22>3.0.CO;2-P
  9. Richards AJ, Morgan J, Bearcroft PW, Pickering E, Owen MJ, Holmans P, et al. Vitreoretinopathy with phalangeal epiphyseal dysplasia, a type II collagenopathy resulting from a novel mutation in the C-propeptide region of the molecule. J Med Genet 2002;39:661-5. https://doi.org/10.1136/jmg.39.9.661
  10. Zankl A, Zabel B, Hilbert K, Wildhardt G, Cuenot S, Xavier B, et al. Spondyloperipheral dysplasia is caused by truncating mutations in the C-propeptide of COL2A1. Am J Med Genet Part A 2004;129A:144-8. https://doi.org/10.1002/ajmg.a.30222
  11. Kaibara N, Yokoyama K, Nakano H. Torrance type of lethal neonatal short-limbed platyspondylic dwarfism. Skeletal Radiol 1983;10:17-9. https://doi.org/10.1007/BF00355385
  12. Freisinger P, Bonaventure J, Stoess H, Pontz BF, Emmrich P, Nerlich A. Type II collagenopathies: are there additional family members? Am J Med Genet 1996;63:137-43. https://doi.org/10.1002/(SICI)1096-8628(19960503)63:1<137::AID-AJMG24>3.0.CO;2-O
  13. Lyn S. Douglas G. Chart of fetal size : limb bones. BJOG 2002;109:919-29. https://doi.org/10.1111/j.1471-0528.2002.01022.x
  14. Yoo HJ, Park SE, Park SO, Park JH, Kim SY. A case of sponduloepiphyseal dysplasia congenital. Korean J Pediatr 1997;40:716-20.
  15. Tamaru S, KiKuchi A, Takagi K, Wakamatsu M, Ono K, Horikoshi T, et al. Prenatal diagnosis of platyspondylic skeletal dysplasia Torrance type with three-dimensional helical computed tomography. Prenat Diagn 2009;29:1282-4. https://doi.org/10.1002/pd.2406
  16. Brodie SG, Kitoh H, Lachman RS, Nolasco LM, Mekikian PB, Wilcox WR. Platyspondylic lethal skeletal dysplasia, San Diego type, is caused by FGFR3 mutations. Am J Med Genet 1999;84:476-80. https://doi.org/10.1002/(SICI)1096-8628(19990611)84:5<476::AID-AJMG12>3.0.CO;2-X
  17. Kannu P, Bateman J, Savarirayan R. Clinical phenotypes associated with type II collagen mutation. J Paediatr Child Health. 2012;48:E38-43. doi:10.1111/j.1440-1754.2010.01979.x.